ORPH - Orphazyme A/S - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Orphazyme A/S's activity chart (see below) currently has 4 price targets and 4 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 40% with an average time for these price targets to be met of 30 days.

Most recent stock forecast was given by YATIN SUNEJA from GUGGENHEIM on 21-Jun-2021. First documented stock forecast 26-Oct-2020.

Best performing analysts who are covering ORPH - Orphazyme A/S:

Tazeen Ahmad Yatin Suneja Ritu Baral

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 21-Jun-2021

$27

5 years 2 months 24 days ago
(21-Jun-2021)

0/1 (0%)

$16.35 (153.52%)

Sell Since 30-Mar-2021

$5

$4.66 (1370.59%)

$13

5 years 5 months 15 days ago
(30-Mar-2021)

2/2 (100%)

$-4.28 (-46.12%)

75

Buy Since 26-Oct-2020

$23

$22.66 (6664.71%)

$23

5 years 8 months 17 days ago
(28-Dec-2020)

0/2 (0%)

$11.73 (104.08%)

Show more analysts

Please expand the browser size to see the chart

What is ORPH (Orphazyme A/S) average time for price targets to be met?

On average it took 30 days for the stock forecasts to be reached, with an average price target met ratio of 40%.

Which analyst most recently updated their price target on ORPH (Orphazyme A/S)?

Yatin Suneja

Which analyst has the most public recommendations on ORPH (Orphazyme A/S)?

Yatin Suneja works at GUGGENHEIM and has 6 price targets and 6 ratings on ORPH

Which analyst is the currently most bullish on ORPH (Orphazyme A/S)?

Ritu Baral with the highest potential upside of $22.66

Which analyst is the currently most reserved on ORPH (Orphazyme A/S)?

Yatin Suneja with the lowest potential downside of -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?